Cases 1 - 10 of 83
Neurocrine Biosciences, Inc. v. Zydus Pharmaceuticals (USA) Inc. et al
as 1:2023cv00266
Defendant:
Zydus Lifesciences Limited formerly known as Cadila Healthcare Limited doing business as Zydus Cadila, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC and others
Plaintiff:
Neurocrine Biosciences, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
NEUROCRINE BIOSCIENCES, INC. v. ZYDUS PHARMACEUTICALS (USA) INC. et al
as 3:2022cv05830
Defendant:
ZYDUS LIFESCIENCES LIMITED, ZYDUS PHARMACEUTICALS (USA) INC., ZYDUS WORLDWIDE DMCC and others
Plaintiff:
NEUROCRINE BIOSCIENCES, INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Neurocrine Biosciences, Inc. v. Zydus Pharmaceuticals (USA) Inc. et al
as 1:2022cv01291
Defendant:
Zydus Lifesciences Limited formerly known as Cadila Healthcare Limited doing business as Zydus Cadila, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC and others
Plaintiff:
Neurocrine Biosciences, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
MYLAN INC. et al v. SOMAXON PHARMACEUTICALS, INC. et al
as 2:2022cv03944
Petitioner:
MYLAN INC. and MYLAN PHARMACEUTICALS INC.,
Plaintiff:
SOMAXON PHARMACEUTICALS, INC. and PROCOM ONE INC.
Respondent:
Currax Pharmaceuticals LLC, Currax Holdings LLC and Currax Holdings USA LLC
Interested Party:
PAR PHARMACEUTICAL INC, ACTAVIS ELIZABETH LLC, ACTAVIS INC. and others
Cause Of Action: 28 U.S.C. § 1338 Patent Infringement
Somaxon Pharmaceuticals, Inc. et al v. ACTAVIS ELIZABETH et al
as 3:2022xc01290
Plaintiff:
Somaxon Pharmaceuticals Inc and Procom One Inc
Defendant:
Actavis Elizabeth LLC, Actavis Inc, Zydus Pharmaceuticals (USA), Inc. and others
Cause Of Action: 28 U.S.C. § 1330 Breach of Contract
Neurocrine Biosciences, Inc. v. Zydus Pharmaceuticals (USA) Inc. et al
as 1:2022cv00439
Defendant:
Zydus Lifesciences Limited formerly known as Cadila Healthcare Limited doing business as Zydus Cadila, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC and others
Plaintiff:
Neurocrine Biosciences, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
NEUROCRINE BIOSCIENCES, INC. v. ZYDUS PHARMACEUTICALS (USA) INC. et al
as 1:2022cv01882
Plaintiff:
NEUROCRINE BIOSCIENCES, INC.
Defendant:
ZYDUS PHARMACEUTICALS (USA) INC., ZYDUS WORLDWIDE DMCC, ZYDUS HEALTHCARE (USA) LLC and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED v. ZYDUS PHARMACEUTICALS (USA) INC. et al
as 2:2022cv01592
Plaintiff:
MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
Defendant:
ZYDUS PHARMACEUTICALS (USA) INC. and CADILA HEALTHCARE LIMITED
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED v. ZYDUS PHARMACEUTICALS (USA) INC. et al
as 3:2022cv01592
Plaintiff:
MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
Defendant:
ZYDUS PHARMACEUTICALS (USA) INC. and CADILA HEALTHCARE LIMITED
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Neurocrine Biosciences, Inc. v. Zydus Pharmaceuticals (USA) Inc. et al
as 1:2021cv01553
Plaintiff:
Neurocrine Biosciences, Inc.
Defendant:
Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC, Zydus Healthcare (USA) LLC and others
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
